Cancer News and Research

Latest Cancer News and Research

MD Anderson, UH Graduate College of Social Work announce new joint venture

The University of Houston (UH) will soon open its doors to the Center for Health Equity & Evaluation Research (CHEER), a new joint venture between the UH Graduate College of Social Work (GCSW) and the University of Texas MD Anderson Cancer Center Division of Cancer Prevention and Population Sciences. CHEER will expand to conduct research at both MD Anderson and the newly opened center at UH GCSW.

2 May 2012

Risk from cancer overshadows risk from CT radiation-induced malignancy

Young patients who undergo chest or abdominopelvic CT are more than 35 times more likely to die of their disease than develop a radiation induced cancer, according to an analysis of 23,359 patients, some of whom were scanned more than 15 times.

2 May 2012

Combination of new prostate cancer drugs can extend life for men

Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they benefit, research led by The Institute of Cancer Research (ICR) has shown.

2 May 2012

Endocrine Society and its Hormone Health Network release ‘Menopause Map’

Women going through menopause now have a first-of-its-kind interactive guide to help them better understand their menu of treatment options, including whether hormone therapy may be right for them. The Endocrine Society and its Hormone Health Network today released the "Menopause Map," an online tool to help women and their doctors discuss which hormonal and non-hormonal treatment options would be most effective and safe to relieve the sometimes debilitating symptoms of menopause.

2 May 2012

New studies restart debate about mammography for women in their 40s

Another study in today's news examines two eye drugs and finds they are comparable, a conclusion that could potentially save Medicare and other insurers millions of dollars.

2 May 2012

BD second quarter revenues increase 3.6% to $1.991 billion

BD, a leading global medical technology company, today reported quarterly revenues of $1.991 billion for the second fiscal quarter ended March 31, 2012, representing an increase of 3.6 percent from the prior-year period, or 4.6 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 2 May 2012

NKCC1 protein may hold clues to how glioblastoma moves and invades

Johns Hopkins researchers have discovered that a protein that transports sodium, potassium and chloride may hold clues to how glioblastoma, the most common and deadliest type of brain cancer, moves and invades nearby healthy brain tissue.

2 May 2012

SCPC accredits Porter Adventist Hospital as Chest Pain Center

The Society of Chest Pain Centers (SCPC) recently awarded Porter Adventist Hospital full accreditation status as a Chest Pain Center.

2 May 2012

Beta-carotene-derived molecules have opposite effect in the body

New research suggests that there could be health hazards associated with consuming excessive amounts of beta-carotene.

2 May 2012

Vanity and fashion trends affect women's health

Fashion trends and concerns about appearance could be having a detrimental effect on the health and fitness of our nation's women according to a new survey commissioned by Cancer Research UK's Race for Life, in partnership with Tesco.

2 May 2012

Cancer genomes in a common database and computation of disease drivers

The emerging field of "personalized" or "precision" medicine holds great promise in the fight against cancer. If scientists can identify the genetic changes that drive each patient's cancer cells, they can use that information to develop targeted treatments. But achieving this goal will require massive amounts of genomic and clinical data and a sophisticated infrastructure to manage and analyze the data.

2 May 2012

Non-toxic green tea shampoo to treat dandruff

Dandruff sufferers now have a non-toxic product to treat the condition, says a researcher at Georgia Health Sciences University.

2 May 2012

Idera to present data from IMO-8400 preclinical studies on SLE, psoriasis at AAI meeting

Idera Pharmaceuticals, Inc. today announced that it will be presenting data from preclinical studies of its Toll-like receptor (TLR) inhibitor, IMO-8400, in models of systemic lupus erythematosus (SLE) and psoriasis, which suggest that IMO-8400 may be useful for the treatment of both indications.

2 May 2012

Exact Sciences first quarter net loss increases to $10.6 million

Exact Sciences Corp. today announced its financial results for the quarter ended March 31, 2012.

2 May 2012

Ciprofloxacin, TMP-SMX no longer safe for outpatient urinary tract infection

In a surveillance study of over 12 million bacteria, investigators at The George Washington University and Providence Hospital found E. coli antimicrobial resistance to ciprofloxacin, the most commonly prescribed antimicrobial for urinary tract infections in the U.S., increased over five-fold from 2000 to 2010.

2 May 2012

Chemo-radiotherapy combination a viable alternative for frail bladder cancer patients

Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to those given radiotherapy alone, a major trial funded by Cancer Research UK shows.

2 May 2012

CHR-3996 pill shows promise against advanced cancers

Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research.

2 May 2012

Weight loss reduces inflammation in postmenopausal women

Postmenopausal women who were overweight or obese and lost at least 5 percent of their body weight had a measurable reduction in markers of inflammation, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

2 May 2012

Seed localization improves satisfaction of breast cancer patients

A cutting-edge procedure called seed localization is improving patient satisfaction at The Dubin Breast Center of the Tisch Cancer Institute at The Mount Sinai Medical Center. In patients undergoing lumpectomy for cancers that are small and cannot be felt in the breast, a tiny radioactive seed is guided into the breast and implanted at the site of the tumor.

2 May 2012

Tyrosine kinases could act as drivers for growth and survival of sarcomas

To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.

2 May 2012